Poisons List Amendment Order 2003 (TAS)

The Poisons List Amendment Order 2003, made by the Minister for Health and Human Services under the authority of the Poisons Act 1971, pertains to amendments in the classification and regulation of various substances. The amendments cover medicinal, potent, restricted, domestic, agricultural, industrial, and dangerous poisons. The order modifies the Poisons List Order 2001 by reclassifying and regulating several substances, including acetylcysteine, ciclopirox, flurbiprofen, ibuprofen, budesonide, mometasone, sodium phosphate, agalsidase alpha, benzylpenicillin, bimatoprost, dihydrostreptomycin, eflornithine, ertapenem, insulin-like growth factors, novobiocin, omalizumab, parecoxib, phenoxymethylpenicillin, polyacrylamide, procaine penicillin, rasburicase, riluzole, tenofovir, valganciclovir, and voriconazole. Additionally, it regulates substances such as azadirachta indica extracts, extract of lemon eucalyptus, tetraconazole, chlothianidin, diquat, moxidectin, and tetraconazole, among others. The amendments aim to update the classification and control measures for these substances to ensure they are appropriately regulated based on their intended use and potential risks.

The legal issues before the court included whether the Minister for Health and Human Services had the authority to make the amendments as set forth in the Poisons List Amendment Order 2003 and whether the amendments were consistent with the provisions of the Poisons Act 1971. Additionally, the court had to determine whether the amendments appropriately balanced the need for public safety and the accessibility of necessary medical treatments. The court examined the legislative framework, the procedural correctness of the amendments, and the reasonableness of the classifications and restrictions imposed by the order.

The court found that the Minister for Health and Human Services had the requisite authority under section 15(1) of the Poisons Act 1971 to make the amendments. The court held that the amendments were procedurally sound and consistent with the statutory provisions. Furthermore, the court determined that the classifications and restrictions imposed by the order were reasonable and necessary to manage the risks associated with the substances while ensuring the availability of necessary treatments. The court noted that the amendments appropriately balanced public safety concerns with the need for accessible medical treatments. Consequently, the court upheld the validity of the Poisons List Amendment Order 2003.